ALEC (Alector) DeferredTaxAndRevenue: $6.72 Mil (As of Mar. 2026)

Alector ALEC -0.25% 30 DeferredTaxAndRevenue is $6.72 Mil as of Mar. 2026. GuruFocus rates ALEC with a GF Score™ of 30/100 and a GF Value™ of $0.73 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Alector's current deferred tax and revenue for the quarter that ended in Mar. 2026 was $6.72 Mil.

Alector DeferredTaxAndRevenue Related Terms

Alector DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Alector's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alector DeferredTaxAndRevenue Chart

Alector Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

DeferredTaxAndRevenue

Get a 7-Day Free Trial

90.80

48.23

82.98

23.66

6.68

Alector Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
DeferredTaxAndRevenue	Get a 7-Day Free Trial															21.85	13.40	11.74	6.68	6.72

30GF Score

Alector Inc ALEC

DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Frequently Asked Questions Learn more about DeferredTaxAndRevenue →

What does a DeferredTaxAndRevenue of $6.72 Mil mean?

Alector (ALEC) has a DeferredTaxAndRevenue of $6.72 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Alector.

Is Alector's DeferredTaxAndRevenue too high?

Alector's current DeferredTaxAndRevenue is $6.72 Mil. Overall, Alector has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Alector's DeferredTaxAndRevenue compare to TNXP and IMUX?

Alector's DeferredTaxAndRevenue of $6.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good DeferredTaxAndRevenue for a Biotechnology company?

A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high DeferredTaxAndRevenue mean?

A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Alector. Alector's current DeferredTaxAndRevenue is $6.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Alector stock overvalued right now?

Based on GuruFocus' analysis, Alector (ALEC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.73, compared to a current price of $2.01 — trading 174.7% above its estimated fair value. The current DeferredTaxAndRevenue is $6.72 Mil. Alector's overall GF Score™ is 30/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is DeferredTaxAndRevenue calculated?

DeferredTaxAndRevenue is calculated from a company's financial statements. For Alector (ALEC), the current DeferredTaxAndRevenue is $6.72 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alector (ALEC) Overvalued in 2026?

Based on GuruFocus' analysis, Alector stock appears to be overvalued. The current stock price of $2.01 is trading 174.7% above its estimated GF Value™ of $0.73. GuruFocus considers Alector to be Significantly Overvalued.

Key valuation signals for ALEC:

DeferredTaxAndRevenue: $6.72 Mil
GF Value™: $0.73 vs. price of $2.01 (174.7% above fair value)
GF Score™: 30/100 with 7 warning signs

No single metric tells the full story. See the ALEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alector Business Description

Industry Healthcare Biotechnology

Comparable Companies TNXP IMUX WHWK TTRX NERV NKTX VYGR KROS CDXS NGEN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, USA, 94080

Website https://www.alector.com

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

30GF Score

Get the complete analysis for ALEC

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.01

Price

$0.73

GF Value

View ALEC Analysis

See DeferredTaxAndRevenue data for all stocks →